People await to get vaccinated at the BKC Covid Centre, Bandra.
People await to get vaccinated at the BKC Covid Centre, Bandra.
BL Soni

Biocon Executive Chairman Kiran Mazumdar-Shaw has expressed concern over the shortage of COVID-19 vaccines. She stated that maybe these vaccines are just lying in the warehouse rather than reaching people. She feels this lacuna can only be addressed by bringing in better transparency.

Mazumdar-Shaw said in a tweet on Tuesday while tagging the Health Ministry, wrote, “Very concerned about why vaccines are in such short supply. Can we please know where the 70 million doses are being deployed every month? @MoHFW_INDIA We need better transparency to avoid the suspense. If a timetable of supplies is made public people can patiently wait their turn."

Responding to a Twitter user who questioned the production capacity of the vaccine producers, she stated, “My fear is vaccines are remaining in warehouses instead of being jabbed into peoples’ arms.”

However, this claim by Shaw was faced by criticism as well. Some Twitter users stated that the government has been transparent about their vaccination drive.

Another individual claimed the low numbers could be because vaccines are getting damaged because of bad logistics and handling.

Earlier this month, while responding to media reports alleging that centre has not placed any fresh order for COVID-19 vaccines, the Health Ministry had noted that a 100 per cent advance of Rs 1,732.50 crore has been released to the Serum Institute of India (SII) on April 28 for 11 crore doses of Covishield vaccine during May, June and July.

India has announced the expansion of its COVID-19 vaccination drive by allowing its large population aged over 18 to get inoculated from May 1.

The ministry had also stated that against the last order of 10 crore doses for supplies of Covishield vaccine, 8.744 crore doses have been delivered till May 3.

SII had endorsed the government statement and said it had received the orders.

The Health Ministry had further noted that 100 per cent advance of Rs 787.50 crore was released on April 28 to Bharat Biotech India Ltd (BBIL) for five crore Covaxin doses during May, June and July.

Bharat Biotech Joint Managing Director Suchitra Ella confirmed in a tweet that the vaccine major has commenced direct supply of 'Covaxin' to 14 states, including Delhi and Maharashtra, with effect from May 1.

(With Input from Agencies)

(To receive our E-paper on whatsapp daily, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

Free Press Journal